CI News

DOJ Investigates UnitedHealth, Probe Accuses Of Inflating Medicare Diagnoses

CI

The Justice Department is investigating UnitedHealth's Medicare billing practices, focusing on diagnoses that led to higher federal payments. The probe follows reports that the company received billions for questionable diagnoses in its Medicare Advantage plans.

February 21, 2025
Read more →

FTC Says UnitedHealth, CVS, Cigna Make Billions Via PBMs On Specialty Drugs

CI

FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for patients and health plan sponsors.

January 15, 2025
Read more →

Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System

CI

PBMs Express Scripts, Caremark, and Optum challenge the FTC's administrative proceedings, arguing it violates constitutional rights and threatens the stability of drug pricing.

November 20, 2024
Read more →

Reported November 19, 2024 CVS, Cigna, UnitedHealth Sue To Nix FTC Case On Insulin Cost - Bloomberg Law

CI

November 20, 2024
Read more →

Piper Sandler Reiterates Overweight on Cigna, Raises Price Target to $394

CI

November 5, 2024
Read more →

Barclays Maintains Overweight on Cigna, Raises Price Target to $420

CI

November 5, 2024
Read more →

Deutsche Bank Maintains Buy on Cigna, Lowers Price Target to $394

CI

November 4, 2024
Read more →

Stephens & Co. Reiterates Overweight on Cigna, Maintains $410 Price Target

CI

November 1, 2024
Read more →

RBC Capital Maintains Outperform on Cigna, Lowers Price Target to $377

CI

November 1, 2024
Read more →

Cigna Healthcare And Mobile-Based Infirmary Health Have Reached An Agreement That Allows Cigna Healthcare's Medicare Advantage Customers To Have In-network Access To Infirmary Health's Hospitals, Facilities And Doctors

CI

November 1, 2024
Read more →

Cigna's Q3 Profit Beats Street On Strong Demand For Pharmacy Benefit Management's Specialty Drugs, New Clients

CI

Cigna reports Q3 sales of $63.7 billion, a 30% YoY increase, driven by Evernorth growth. Adjusted EPS of $7.51 beats estimates. 2024 EPS guidance reaffirmed.

October 31, 2024
Read more →

Cigna Expects Full Year 2024 Medical Care Ratio Of 81.7%-82.5%

CI

October 31, 2024
Read more →

Cigna Reaffirms Full Year 2024 Consolidated Adjusted EPS From Operations Of At Least $28.40 Versus Consensus Of $28.5

CI

October 31, 2024
Read more →

Cigna Group Q3 2024 Adj EPS $7.51 Beats $7.20 Estimate, Sales $63.70B Beat $59.35B Estimate

CI

October 31, 2024
Read more →

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,800 Today

CI

May 16, 2024
Read more →

Cigna Whale Trades Spotted

CI

A whale with a lot of money to spend has taken a noticeably bearish stance on Cigna. Looking at options history for Cigna (NYSE:CI) we detected 10 strange trades.

September 14, 2022
Read more →

Cigna Corps Expects To Reaffirm Projected Full Year 2022 Consolidated Adj. EPS Guidance Of At Least $22.90

CI

September 13, 2022
Read more →

Cigna Q1 2022 Earnings Conference Call On May 6, 2022 At 08:30 AM ET

CI

Cigna (NYSE:CI) will host a conference call at 08:30 AM ET on May 6, 2022, to discuss Q1 2022 earnings results. How to Attend Cigna (CI) Conference Call Follow this link to access the live webcast.

May 2, 2022
Read more →